1 |
Tsou PS, Varga J, O'Reilly S. Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential. Nat Rev Rheumatol 2021;17:596-607. [PMID: 34480165 DOI: 10.1038/s41584-021-00683-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Dai B, Ding L, Zhao L, Zhu H, Luo H. Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights. Front Pharmacol 2022;13:826839. [DOI: 10.3389/fphar.2022.826839] [Reference Citation Analysis]
|
3 |
Servaas NH, Mariotti B, van der Kroef M, Wichers CGK, Pandit A, Bazzoni F, Radstake TRDJ, Rossato M. Characterization of Long Non-Coding RNAs in Systemic Sclerosis Monocytes: A Potential Role for PSMB8-AS1 in Altered Cytokine Secretion. Int J Mol Sci 2021;22:4365. [PMID: 33922041 DOI: 10.3390/ijms22094365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Larsen SB, Cowley CJ, Sajjath SM, Barrows D, Yang Y, Carroll TS, Fuchs E. Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 2021:S1934-5909(21)00286-1. [PMID: 34320411 DOI: 10.1016/j.stem.2021.07.001] [Reference Citation Analysis]
|
5 |
Grandi FC, Modi H, Kampman L, Corces MR. Chromatin accessibility profiling by ATAC-seq. Nat Protoc 2022. [PMID: 35478247 DOI: 10.1038/s41596-022-00692-9] [Reference Citation Analysis]
|
6 |
Xu Q, Georgiou G, Frölich S, van der Sande M, Veenstra GJC, Zhou H, van Heeringen SJ. ANANSE: an enhancer network-based computational approach for predicting key transcription factors in cell fate determination. Nucleic Acids Res 2021:gkab598. [PMID: 34244796 DOI: 10.1093/nar/gkab598] [Reference Citation Analysis]
|